Oncology Times Broadcast News with the Audio Journal of Oncology - January 2009

Oncology Times Broadcast News January 9th, 2009 American Society of Hematology 2008 Meeting Report Reporting From the 2008 Annual Meeting of the American Society of Hematology, San Francisco The exciting recent ASH conference reflected the vibrant mood of an America boldly tackling economic and political turmoil with post-presidential-election optimism. Peter Goodwin and George Canellos reflect on some of the big stories and talk with key investigators in San Francisco. Francesco Zaja recounts how rituximab has proved effective for treating immune thrombocytopenic purpura (ITP); Hannes Wandt presents compelling data suggesting that platelet transfusions can be withheld in many patients receiving stem cell transplants for their hematologic malignancies; and both Michael Hallek and Tadeusz Robak announce Phase III study findings of improved benefits for patients whose chronic lymphocytic leukemia has been treated by adding rituximab to standard chemotherapy. The ASH President, Kenneth Kaushansky, plus Linda Burns and George Canellos contribute their comments to put the new findings into clinical perspective for the busy oncologist.

You can listen to Oncology Times Broadcast News with the Audio Journal of Oncology - January 2009 online on Radio and Podcast. Open the player on this page to stream the available audio.

Oncology Times Broadcast News with the Audio Journal of Oncology - January 2009 is an episode from Oncology Times Broadcast News.

This episode is 00:26:57 long.

This episode was published on Jan 7, 2009.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Oncology Times Broadcast News when more episodes are available from the podcast feed.